Elevatus财富管理和美国世纪公司刺激了对Abbott实验室的投资,Abbott实验室是一家主要的医疗保健公司。 Elevatus Wealth Management and American Century Companies boost investments in Abbott Labs, a leading healthcare firm.

Elevatus财富管理和美国世纪公司公司最近增加了对Abbott实验室的投资,Abbott实验室是主要的保健产品制造者。 Elevatus Wealth Management and American Century Companies Inc. have recently increased their investments in Abbott Laboratories, a major healthcare product maker. Abbott报告说,Q2的收益为每股1.26美元,达到了预期,收入为11.14亿美元,略高于预测。 Abbott reported Q2 earnings of $1.26 per share, meeting expectations, with revenue at $11.14 billion, slightly above forecasts. 股价是144.47美元 The stock has a "Moderate Buy" rating and a target price of $144.47. Abbott在药品、诊断、营养和医疗设备等领域运作。 Abbott operates in areas such as pharmaceuticals, diagnostics, nutrition, and medical devices.